Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

serdexmethylphenidate/ dexmethylphenidate

serdexmethylphenidate/ dexmethylphenidate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Azstarys CAPSULE, ORAL 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg    
Comments:

Adults: (refer to interchange table below)

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

Azstarys

  • 26.1 mg/5.2 mg once daily
  • 39.2 mg/7.8 mg once daily
  • 52.3 mg/10.4 mg once daily

dexmethylphenidate

  • 20 mg ER once daily
  • 30 mg ER once daily
  • 40 mg ER once daily

 

Pediatrics: A drug holiday is recommended or inpatients may use home supply.

Reviewed: June 2023 (Azstarys)

Spotlight Serdexmethylphenidate (Azstarys)

Last updated: Aug. 28, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved